Nibbling at CRF receptor control of feeding and gastrocolonic motility (Q35198041)

7 August 2017

1 reference

title

Nibbling at CRF receptor control of feeding and gastrocolonic motility (English)

1 reference

7 August 2017

2

Yvette Taché

1 reference

7 August 2017

3

George F Koob

1 reference

7 August 2017

Eric P Zorrilla

1

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Trends in Pharmacological Sciences

7 August 2017

published in

1 reference

7 August 2017

volume

24

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

421-427

1 reference

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The CRF peptide family and their receptors: yet more partners discovered

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Design, synthesis and pharmacological characterization of new highly selective CRF(2) antagonists: development of 123I-K31440 as a potential SPECT ligand

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Secondary structure of antisauvagine analogues is important for CRF receptor antagonism: development of antagonists with increased potency and receptor selectivity

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The inhibitory effect of hormones associated with stress on Na appetite of sheep

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2).

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Peripheral CRF activates myenteric neurons in the proximal colon through CRF(1) receptor in conscious rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

The physiology of corticotropin-releasing hormone deficiency in mice

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Novel peptide-peptide cooperation may transform feeding behavior

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Intravenous urocortin II decreases blood pressure through CRF(2) receptor in rats

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Neuroprotective effects of the CRF1 antagonist R121920 after permanent focal ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Pharmacological characterization of a novel nonpeptide antagonist radioligand, ( /-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Bi

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00177-9

7 January 2021

10.1016/S0165-6147(03)00177-9

Identifiers

DOI

1 reference

7 August 2017

1 reference